IRCT20200825048515N60 IRCT 2022-09-12 Esfahan University of Medical Sciences Comparing the effect of "bupivacaine" with "bupivacaine plus dexmedetomidine" in reducing pain after caesarean section. Comparing the preventive effect of infiltration into the surgical incision "bupivacaine" with "bupivacaine plus dexmedetomidine" in reducing pain after caesarean section. 2022-09-22 anticipated 80 Complete https://irct.ir/trial/65520 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, 80 eligible patients are randomly selected. Then the letters A and B are written on 400 sheets and each one is placed in an envelope. Each patient is then asked to choose one of the envelopes. Depending on the selected envelope, the patient is assigned to one of two groups, Blinding description: In order to achieve the double-blind study, two drugs, bupivacaine and the combination of bupivacaine and dexmedetomidine, will be prepared and placed in the bag daily before surgery (without the knowledge of the researcher) and will be labeled A, B. And is given daily to the anesthesiologist (researcher). Therefore, the patient, care provider, investigator, outcome assessor, and data analyzer will not be aware of the type of intervention. 2 Cesarean delivery. Intervention 1: First intervention group: In this group, local subcutaneous wound infiltration of 0.25% bupivacaine (3 mg/kg) diluted with normal saline up to 40 ml will be done. Intervention 2: Second intervention group: In this group, local subcutaneous wound infiltration of 0.25% bupivacaine (3 mg/kg) plus dexmedetomidine (1.5 μg/kg) of body weight diluted with normal saline up to 40 ml will be done. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information